Regulations

Catwalk Cosmetic Laboratories Gets a Warning Letter from the US FDA

South African company cited for failure to follow CGMPs.

Catwalk Cosmetic Laboratories Pty Ltd., Muizenberg Western Cape, South Africa, received a Warning Letter from the US Food and Drug Administration on Nov. 21, 2024. According to the FDA, the company’s manufacturing facility in South Africa violates several Current Good Manufacturing Practices (CGMP). These violations include: • Failure to conduct at least one test to verify the identity of each component of a drug product. • Failure to have, for each batch of drug product, appropr...

Continue reading this story and get 24/7 access to Happi for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Happi Newsletters